Ensysce Biosciences (ENSC) Misses Q2 EPS by 79c

Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.

For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.

You May Also Be Interested In

• Sinda opens at $10.80, IPO priced at $12
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'